In this issue: Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
The updated practice guidelines for the treatment of atrial fibrillation include information on the newer treatments for rhythm control, treatment options to reduce atrial fibrillation complications, and updated anticoagulant management for thromboprophylaxis.
Long-term Mortality Among Adults with Asthma; Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes; New Hope for Hepatitis C Patients
A new serotonin and norepinephrine reuptake inhibitor (SNRI) has been approved by the FDA for the treatment of major depressive disorder (MDD).
In a large, international observational study, patients who had repair of flail mitral valve leaflets within 3 months of diagnosis had better long-term survival and a lower risk of heart failure than those managed with watchful waiting.
Catheter-related bloodstream infections (CRBSIs) cause significant morbidity and mortality.
This observational cohort study was conducted among 1.25 million adults from 4 private US healthcare organizations (HCO): Geisinger Health System, Danville, Pennsylvania; Henry Ford Health System, Detroit, Michigan; Kaiser Permanente-Northwest, Portland, Oregon; Kaiser Permanente, Honolulu, Hawaii. The study included persons who had ≥1 clinical encounter during 2006-2008 and ≥12 months of follow-up before 2009.